Logo image of ALFEN.AS

ALFEN N.V. (ALFEN.AS) Stock Fundamental Analysis

Europe - AMS:ALFEN - NL0012817175 - Common Stock

9.8 EUR
-0.03 (-0.28%)
Last: 10/22/2025, 3:01:23 PM
Fundamental Rating

4

Taking everything into account, ALFEN scores 4 out of 10 in our fundamental rating. ALFEN was compared to 61 industry peers in the Electrical Equipment industry. While ALFEN seems to be doing ok healthwise, there are quite some concerns on its profitability. ALFEN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ALFEN had negative earnings in the past year.
In the past year ALFEN had a positive cash flow from operations.
Of the past 5 years ALFEN 4 years were profitable.
Each year in the past 5 years ALFEN had a positive operating cash flow.
ALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

The Return On Assets of ALFEN (-5.09%) is worse than 60.66% of its industry peers.
ALFEN has a Return On Equity (-11.40%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ALFEN.AS Yearly ROA, ROE, ROICALFEN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

ALFEN has a Gross Margin (34.60%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ALFEN has declined.
The Profit Margin and Operating Margin are not available for ALFEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
ALFEN.AS Yearly Profit, Operating, Gross MarginsALFEN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

ALFEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALFEN remains at a similar level compared to 1 year ago.
ALFEN has more shares outstanding than it did 5 years ago.
ALFEN has a better debt/assets ratio than last year.
ALFEN.AS Yearly Shares OutstandingALFEN.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALFEN.AS Yearly Total Debt VS Total AssetsALFEN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.61 indicates that ALFEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALFEN has a better Altman-Z score (2.61) than 68.85% of its industry peers.
The Debt to FCF ratio of ALFEN is 0.99, which is an excellent value as it means it would take ALFEN, only 0.99 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALFEN (0.99) is better than 93.44% of its industry peers.
ALFEN has a Debt/Equity ratio of 0.26. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.26, ALFEN is doing good in the industry, outperforming 68.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Altman-Z 2.61
ROIC/WACCN/A
WACC7.37%
ALFEN.AS Yearly LT Debt VS Equity VS FCFALFEN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALFEN has a Current Ratio of 1.75. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.75, ALFEN is doing good in the industry, outperforming 63.93% of the companies in the same industry.
ALFEN has a Quick Ratio of 1.09. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
ALFEN has a better Quick ratio (1.09) than 67.21% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.09
ALFEN.AS Yearly Current Assets VS Current LiabilitesALFEN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

ALFEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -287.72%.
The Revenue for ALFEN has decreased by -13.84% in the past year. This is quite bad
ALFEN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.79% yearly.
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%

3.2 Future

Based on estimates for the next years, ALFEN will show a very strong growth in Earnings Per Share. The EPS will grow by 39.04% on average per year.
The Revenue is expected to grow by 2.90% on average over the next years.
EPS Next Y102.15%
EPS Next 2Y100%
EPS Next 3Y75.65%
EPS Next 5Y39.04%
Revenue Next Year-7.68%
Revenue Next 2Y-1.24%
Revenue Next 3Y1.55%
Revenue Next 5Y2.9%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALFEN.AS Yearly Revenue VS EstimatesALFEN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
ALFEN.AS Yearly EPS VS EstimatesALFEN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALFEN. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 30.69, the valuation of ALFEN can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALFEN is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, ALFEN is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 30.69
ALFEN.AS Price Earnings VS Forward Price EarningsALFEN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ALFEN.
Based on the Price/Free Cash Flow ratio, ALFEN is valued cheaper than 96.72% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.29
EV/EBITDA 26.8
ALFEN.AS Per share dataALFEN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

ALFEN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALFEN's earnings are expected to grow with 75.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y100%
EPS Next 3Y75.65%

0

5. Dividend

5.1 Amount

ALFEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ALFEN N.V.

AMS:ALFEN (10/22/2025, 3:01:23 PM)

9.8

-0.03 (-0.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-04 2025-11-04
Inst Owners42.06%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap213.15M
Revenue(TTM)453.43M
Net Income(TTM)-17252000
Analysts41.25
Price Target10.67 (8.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-14.79%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-99.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-9.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.69
P/S 0.47
P/FCF 4.29
P/OCF 3.28
P/B 1.41
P/tB 1.75
EV/EBITDA 26.8
EPS(TTM)-0.79
EYN/A
EPS(NY)0.32
Fwd EY3.26%
FCF(TTM)2.28
FCFY23.3%
OCF(TTM)2.99
OCFY30.49%
SpS20.85
BVpS6.96
TBVpS5.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.09%
ROE -11.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.6%
FCFM 10.95%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.26
Debt/FCF 0.99
Debt/EBITDA 4.36
Cap/Depr 56.5%
Cap/Sales 3.38%
Interest Coverage N/A
Cash Conversion 709.26%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.09
Altman-Z 2.61
F-Score5
WACC7.37%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-287.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.16%
EPS Next Y102.15%
EPS Next 2Y100%
EPS Next 3Y75.65%
EPS Next 5Y39.04%
Revenue 1Y (TTM)-13.84%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%-13.92%
Revenue Next Year-7.68%
Revenue Next 2Y-1.24%
Revenue Next 3Y1.55%
Revenue Next 5Y2.9%
EBIT growth 1Y-211.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year691.73%
EBIT Next 3Y125.96%
EBIT Next 5Y65.41%
FCF growth 1Y164.76%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y242.64%
OCF growth 3Y74.32%
OCF growth 5Y31.69%